Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;114(1):100-5.
doi: 10.1289/ehp.8149.

Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation

Marleen Maras  1 , Caroline Vanparys, Frederik Muylle, Johan Robbens, Urs Berger, Jonathan L Barber, Ronny Blust, Wim De Coen
Affiliations

Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation

Marleen Maras et al. Environ Health Perspect. 2006 Jan.

Abstract

We investigated estrogen-like properties of five perfluorinated compounds using a combination of three in vitro assays. By means of an E-screen assay, we detected the proliferation-promoting capacity of the fluorotelomer alcohols 1H,1H,2H,2H-perfluorooctan-1-ol (6:2 FTOH) and 1H,1H,2H,2H-perfluoro-decan-1-ol (8:2 FTOH). The more widely environmentally distributed compounds perfluoro-1-octane sulfonate, perfluorooctanoic acid, and perfluorononanoic acid did not seem to possess this hormone-dependent proliferation capacity. We investigated cell cycle dynamics using flow cytometric analyses of the DNA content of the nuclei of MCF-7 breast cancer cells. Exposure to both fluorotelomer alcohols stimulated resting MCF-7 cells to reenter the synthesis phase (S-phase) of the cell cycle. After only 24 hr of treatment, we observed significant increases in the percentage of cells in the S-phase. In order to further investigate the resemblance of the newly detected xenoestrogens to the reference compound 17beta-estradiol (E2), gene expression of a number of estrogen-responsive genes was analyzed by real-time polymerase chain reaction. With E2, as well as 4-nonylphenol and the fluorotelomer alcohols, we observed up-regulation of trefoil factor 1, progesterone receptor, and PDZK1 and down-regulation of ERBB2 gene expression. We observed small but relevant up-regulation of the estrogen receptor as a consequence of exposures to 6:2 FTOH or 8:2 FTOH. The latter finding suggests an alternative mode of action of the fluorotelomer alcohols compared with that of E2. This study clearly underlines the need for future in vivo testing for specific endocrine-related end points.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analysis of estrogenicity of E2 (A), 4-NP (B), 6:2 FTOH (C), 8:2 FTOH (D), PFOS (E), and PFOA (F ) by the E-screen assay in MCF-7 cells. 0.1% DMSO was the solvent control. Results are expressed as mean ± SD of three replicates for each data point.
Figure 2
Figure 2
Histograms of DNA content showing the effects of perfluorinated compounds on cell cycle distribution. (A) 0.1% DMSO (solvent control). Cells were cultured in DMEM plus 5% CSFBS for 72 hr before exposing them to estrogenic compounds (B, 1 nM E2; C, 10 μM 4-NP; D, 30 μM 6:2 FTOH; and E, 10 μM 8:2 FTOH) and non-estrogenic perfluorinated compounds (F, 50 μM PFOS; G, 50 μM PFNA) for 24 hr. 4-NP (C) was the positive control, and 10 nM TCDD (H) was the negative control.
Figure 3
Figure 3
Effect of perfluorinated chemicals on mRNA expression of estrogen-responsive genes in MCF-7 cells were treated with 0.1% DMSO, 1 nM E2, 10 μM 4-NP, 30 μM 6:2 FTOH, 10 μM 8:2 FTOH, 50 μM PFOS, 50 μM PFNA, 50 μM PFOA, or 10 nM TCDD. After exposure to the test compounds for 48 hr, mRNA levels of TFF1 (A), PGR (B), ESR1 (C), PDZK1 (D), and ERBB2 (E) were measured by real-time PCR and normalized using HPRT1 as an internal control. Results are means from three replicate measurements and are expressed as fold relative to 0.1% DMSO; error bars indicate SD. *p < 0.05. **p ≤ 0.001.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Austin ME, Kasturi BS, Barber M, Kannan K, MohanKumar PS, MohanKumar SMJ. Neuroendocrine effects of per-fluorooctane sulfonate in rats. Environ Health Perspect. 2003;111:1485–1489. - PMC - PubMed
    1. Bièche I, Parfait B, Le Doussal V, Olivi M, Rio M, Lidereau R, et al. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res. 2001;61:1652–1658. - PubMed
    1. Coser KR, Chesnes J, Hur J, Ray S, Isselbacher KJ, Shioda T. Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Nat Acad Sci USA. 2003;100:13994–13999. - PMC - PubMed
    1. Degen GH, Bolt HM. Endocrine disruptors: update on xenoestrogens. Int Arch Occup Environ Health. 2000;73:433–441. - PubMed
    1. Dimitrov S, Kamenska V, Walker JD, Windle W, Purdy R, Lewis M, et al. Predicting the biodegradation products of perfluorinated chemicals using CATABOL. SAR QSAR Environ Res. 2004;15:69–82. - PubMed

Publication types

MeSH terms

LinkOut - more resources